Literature DB >> 11331316

Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy.

W Demark-Wahnefried1, B L Peterson, E P Winer, L Marks, N Aziz, P K Marcom, K Blackwell, B K Rimer.   

Abstract

PURPOSE: Weight gain is a common problem among breast cancer patients who receive adjuvant chemotherapy (CT). We undertook a study to determine the causes of this energy imbalance. PATIENTS AND METHODS: Factors related to energy balance were assessed at baseline (within 3 weeks of diagnosis) and throughout 1 year postdiagnosis among 53 premenopausal women with operable breast carcinoma. Thirty-six patients received CT and 17 received only localized treatment (LT). Measures included body composition (dual energy x-ray absorptiometry), resting energy expenditure (REE; indirect calorimetry), dietary intake (2-day dietary recalls and food frequency questionnaires) and physical activity (physical activity records).
RESULTS: Mean weight gain in the LT patients was 1.0 kg versus 2.1 kg in the CT group (P =.02). No significant differences between groups in trend over time were observed for REE and energy intake; however, a significant difference was noted for physical activity (P =.01). Several differences between groups in 1-year change scores were detected. The mean change (+/- SE) in LT versus CT groups and P values for uncontrolled/controlled (age, race, radiation therapy, baseline body mass index, and end point under consideration) analysis are as follows: percentage of body fat (-0.1 +/- 0.4 v +2.2 +/- 0.6%; P =.001/0.04); fat mass (+0.1 +/- 0.3 v +2.3 +/- 0.7 kg; P =.002/0.04); lean body mass (+0.8 +/- 0.2 v -0.4 +/- 0.3 kg; P =.02/0.30); and leg lean mass (+0.5 +/- 0.1 v -0.2 +/- 0.1 kg; P =.01/0.11).
CONCLUSION: These data do not support overeating as a cause of weight gain among breast cancer patients who receive CT. The data suggest, however, that CT-induced weight gain is distinctive and indicative of sarcopenic obesity (weight gain in the presence of lean tissue loss or absence of lean tissue gain). The development of sarcopenic obesity with evidence of reduced physical activity supports the need for interventions focused on exercise, especially resistance training in the lower body, to prevent weight gain.

Entities:  

Mesh:

Year:  2001        PMID: 11331316     DOI: 10.1200/JCO.2001.19.9.2381

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  160 in total

Review 1.  Nutrition and survival after the diagnosis of breast cancer: a review of the evidence.

Authors:  Cheryl L Rock; Wendy Demark-Wahnefried
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

Review 2.  A review of exercise interventions to improve bone health in adult cancer survivors.

Authors:  Kerri M Winters-Stone; Anna Schwartz; Lillian M Nail
Journal:  J Cancer Surviv       Date:  2010-04-07       Impact factor: 4.442

3.  The Benefits of Goal Adjustment Capacities for Well-Being Among Women With Breast Cancer: Potential Mechanisms of Action.

Authors:  Maria G Mens; Michael F Scheier
Journal:  J Pers       Date:  2015-09-10

4.  Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study.

Authors:  Wendy Demark-Wahnefried; Anne Jacobs Kenyon; Pamela Eberle; Ann Skye; William E Kraus
Journal:  Clin Exerc Physiol       Date:  2002-02

5.  Implications of mobility impairment on the diagnosis and treatment of breast cancer.

Authors:  Lisa I Iezzoni; Elyse R Park; Kerry L Kilbridge
Journal:  J Womens Health (Larchmt)       Date:  2010-10-30       Impact factor: 2.681

Review 6.  Dietary Guidelines for Breast Cancer Patients: A Critical Review.

Authors:  Ana Teresa Limon-Miro; Veronica Lopez-Teros; Humberto Astiazaran-Garcia
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

7.  Lifestyle Modification Experiences of African American Breast Cancer Survivors: A Needs Assessment.

Authors:  Selina A Smith; Mechelle D Claridy; Mary Smith Whitehead; Joyce Q Sheats; Wonsuk Yoo; Ernest A Alema-Mensah; Benjamin E-O Ansa; Steven S Coughlin
Journal:  JMIR Cancer       Date:  2015 Jul-Dec

8.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Authors:  James J Dignam; Kelly Wieand; Karen A Johnson; Bernard Fisher; Lei Xu; Eleftherios P Mamounas
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

9.  Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.

Authors:  Jennifer A Ligibel; Ann Partridge; Anita Giobbie-Hurder; Mehra Golshan; Karen Emmons; Eric P Winer
Journal:  Ann Surg Oncol       Date:  2008-10-24       Impact factor: 5.344

Review 10.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.